![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | HSBP1L1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Hsbp1l1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSBP1L1 mRNA | CTD | PMID:36331819 | HSBP1L1 | Human | 1,2-dichloroethane | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of HSBP1L1 mRNA | CTD | PMID:28189721 and PMID:28960355 | HSBP1L1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of HSBP1L1 mRNA | CTD | PMID:22206623 | HSBP1L1 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of HSBP1L1 mRNA | CTD | PMID:23019147 | HSBP1L1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of HSBP1L1 mRNA | CTD | PMID:30165855 | HSBP1L1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSBP1L1 mRNA | CTD | PMID:26377647 | HSBP1L1 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of HSBP1L1 mRNA | CTD | PMID:30851411 | HSBP1L1 | Human | 4,4'-sulfonyldiphenol | affects expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | bisphenol S affects the expression of HSBP1L1 mRNA | CTD | PMID:39298647 | HSBP1L1 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Hsbp1l1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of HSBP1L1 mRNA | CTD | PMID:25825206 | HSBP1L1 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of HSBP1L1 mRNA | CTD | PMID:32763439 | HSBP1L1 | Human | benzo[a]pyrene | increases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of HSBP1L1 mRNA | CTD | PMID:19770486 | HSBP1L1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of HSBP1L1 promoter | CTD | PMID:27901495 | HSBP1L1 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of HSBP1L1 mRNA | CTD | PMID:38218311 | HSBP1L1 | Human | bisphenol A | decreases expression | ISO | Hsbp1l1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of HSBP1L1 mRNA | CTD | PMID:25181051 | HSBP1L1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of HSBP1L1 mRNA | CTD | PMID:38382870 | HSBP1L1 | Human | carbon nanotube | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | HSBP1L1 | Human | chlordecone | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of HSBP1L1 mRNA | CTD | PMID:29980752 | HSBP1L1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSBP1L1 mRNA | CTD | PMID:27188386 | HSBP1L1 | Human | epoxiconazole | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of HSBP1L1 mRNA | CTD | PMID:35436446 | HSBP1L1 | Human | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of HSBP1L1 mRNA | CTD | PMID:29432896 | HSBP1L1 | Human | fenthion | increases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Fenthion results in increased expression of HSBP1L1 mRNA | CTD | PMID:34813904 | HSBP1L1 | Human | genistein | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Genistein results in decreased expression of HSBP1L1 mRNA | CTD | PMID:32186404 | HSBP1L1 | Human | iron atom | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of HSBP1L1 mRNA | CTD | PMID:20368581 | HSBP1L1 | Human | iron(0) | decreases expression | EXP | | 6480464 | Iron deficiency results in decreased expression of HSBP1L1 mRNA | CTD | PMID:20368581 | HSBP1L1 | Human | N-nitrosodiethylamine | increases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of HSBP1L1 mRNA | CTD | PMID:24535843 | HSBP1L1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of HSBP1L1 mRNA | CTD | PMID:26497421 and PMID:29067470 | HSBP1L1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Hsbp1l1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HSBP1L1 mRNA | CTD | PMID:36331819 | HSBP1L1 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of HSBP1L1 mRNA | CTD | PMID:26272509 | HSBP1L1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSBP1L1 mRNA | CTD | PMID:27188386 | HSBP1L1 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of HSBP1L1 mRNA | CTD | PMID:30851411 | HSBP1L1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSBP1L1 mRNA | CTD | PMID:27188386 | HSBP1L1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of HSBP1L1 mRNA | CTD | PMID:38568856 | HSBP1L1 | Human | tamoxifen | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of HSBP1L1 mRNA | CTD | PMID:25123088 | HSBP1L1 | Human | tetrachloromethane | increases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of HSBP1L1 mRNA | CTD | PMID:27339419 and PMID:31919559 | HSBP1L1 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of HSBP1L1 mRNA | CTD | PMID:38568856 | HSBP1L1 | Human | titanium dioxide | decreases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of HSBP1L1 mRNA | CTD | PMID:35295148 | HSBP1L1 | Human | titanium dioxide | decreases methylation | ISO | Hsbp1l1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of HSBP1L1 gene | CTD | PMID:35295148 | HSBP1L1 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of HSBP1L1 mRNA | CTD | PMID:30510588 | HSBP1L1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of HSBP1L1 mRNA | CTD | PMID:37042841 | HSBP1L1 | Human | triptonide | increases expression | ISO | Hsbp1l1 (Mus musculus) | 6480464 | triptonide results in increased expression of HSBP1L1 mRNA | CTD | PMID:33045310 | HSBP1L1 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of HSBP1L1 gene | CTD | PMID:29154799 | HSBP1L1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of HSBP1L1 mRNA | CTD | PMID:25979313 | HSBP1L1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of HSBP1L1 mRNA | CTD | PMID:28001369 | |